Literature DB >> 25901070

Inhibition of hypertrophy, per se, may not be a good therapeutic strategy in ventricular pressure overload: other approaches could be more beneficial.

Bertrand Crozatier1, Renée Ventura-Clapier2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25901070     DOI： 10.1161/CIRCULATIONAHA.114.013895

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  18 in total

1.  A New Pathway for Sympathetic Cardioprotection in Heart Failure.

Authors:  Paul C Simpson
Journal:  Circ Res       Date:  2015-09-11       Impact factor: 17.367

Review 2.  Emerging therapeutic targets for cardiac hypertrophy.

Authors:  Alexander J Winkle; Drew M Nassal; Rebecca Shaheen; Evelyn Thomas; Shivangi Mohta; Daniel Gratz; Seth H Weinberg; Thomas J Hund
Journal:  Expert Opin Ther Targets       Date:  2022-01-27       Impact factor: 6.902

3.  Intraventricular pressure gradients change during the development of left ventricular hypertrophy: Effect of salvianolic acid B and beta-blocker.

Authors:  Danfu Ma; Ahmed S Mandour; Tomohiko Yoshida; Katsuhiro Matsuura; Kazumi Shimada; Pitipat Kitpipatkun; Akiko Uemura; Mayumi Ifuku; Ken Takahashi; Ryou Tanaka
Journal:  Ultrasound       Date:  2021-02-04

Review 4.  Calpains as Potential Therapeutic Targets for Myocardial Hypertrophy.

Authors:  David Aluja; Sara Delgado-Tomás; Marisol Ruiz-Meana; José A Barrabés; Javier Inserte
Journal:  Int J Mol Sci       Date:  2022-04-07       Impact factor: 6.208

5.  βIV-Spectrin regulates STAT3 targeting to tune cardiac response to pressure overload.

Authors:  Sathya D Unudurthi; Drew Nassal; Amara Greer-Short; Nehal Patel; Taylor Howard; Xianyao Xu; Birce Onal; Tony Satroplus; Deborah Hong; Cemantha Lane; Alyssa Dalic; Sara N Koenig; Adam C Lehnig; Lisa A Baer; Hassan Musa; Kristin I Stanford; Sakima Smith; Peter J Mohler; Thomas J Hund
Journal:  J Clin Invest       Date:  2018-11-12       Impact factor: 14.808

Review 6.  The cardiac enigma: current conundrums in heart failure research.

Authors:  Michael S Kapiloff; Craig A Emter
Journal:  F1000Res       Date:  2016-01-18

7.  Myocardial Oxygen Consumption and Efficiency in Aortic Valve Stenosis Patients With and Without Heart Failure.

Authors:  Nils Henrik Stubkjær Hansson; Jens Sörensen; Hendrik Johannes Harms; Won Yong Kim; Roni Nielsen; Lars P Tolbod; Jørgen Frøkiær; Kirsten Bouchelouche; Karen Kaae Dodt; Inger Sihm; Steen Hvitfeldt Poulsen; Henrik Wiggers
Journal:  J Am Heart Assoc       Date:  2017-02-06       Impact factor: 5.501

8.  Dual inhibition of sodium-glucose linked cotransporters 1 and 2 exacerbates cardiac dysfunction following experimental myocardial infarction.

Authors:  Kim A Connelly; Yanling Zhang; Jean-François Desjardins; Kerri Thai; Richard E Gilbert
Journal:  Cardiovasc Diabetol       Date:  2018-07-07       Impact factor: 9.951

Review 9.  Targeting protein-protein interactions in complexes organized by A kinase anchoring proteins.

Authors:  Ana I Calejo; Kjetil Taskén
Journal:  Front Pharmacol       Date:  2015-09-08       Impact factor: 5.810

Review 10.  Epigenetics in heart failure phenotypes.

Authors:  Alexander Berezin
Journal:  BBA Clin       Date:  2016-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.